Logo image of NIM

NUVEEN SELECT MATURIT MUNI (NIM) Stock Price, Quote, News and Overview

NYSE:NIM - New York Stock Exchange, Inc. - US67061T1016 - Currency: USD

9.35  +0.03 (+0.32%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NIM. NIM was compared to 0 industry peers in the Unkown industry. The financial health of NIM is average, but there are quite some concerns on its profitability. NIM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NIM had positive earnings in the past year.
NIM Yearly Net Income VS EBIT VS OCF VS FCFNIM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

The 3 year average ROIC (2.15%) for NIM is below the current ROIC(2.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.73%
ROE 2.76%
ROIC 2.48%
ROA(3y)1.44%
ROA(5y)N/A
ROE(3y)1.44%
ROE(5y)N/A
ROIC(3y)2.15%
ROIC(5y)N/A
NIM Yearly ROA, ROE, ROICNIM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 2 -2 4 6

1.3 Margins

In the last couple of years the Profit Margin of NIM has declined.
In the last couple of years the Operating Margin of NIM has remained more or less at the same level.
In the last couple of years the Gross Margin of NIM has remained more or less at the same level.
Industry RankSector Rank
OM 84.12%
PM (TTM) 73.99%
GM 85.76%
OM growth 3Y-0.12%
OM growth 5YN/A
PM growth 3Y-53.19%
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5YN/A
NIM Yearly Profit, Operating, Gross MarginsNIM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 50 -50 100 150 200

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for NIM remains at a similar level compared to 1 year ago.
There is no outstanding debt for NIM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NIM Yearly Shares OutstandingNIM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M 10M
NIM Yearly Total Debt VS Total AssetsNIM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 50.20 indicates that NIM is not in any danger for bankruptcy at the moment.
NIM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 50.2
ROIC/WACCN/A
WACCN/A
NIM Yearly LT Debt VS Equity VS FCFNIM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.3 Liquidity

NIM has a Current Ratio of 1.17. This is a normal value and indicates that NIM is financially healthy and should not expect problems in meeting its short term obligations.
NIM has a Quick Ratio of 1.17. This is a normal value and indicates that NIM is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
NIM Yearly Current Assets VS Current LiabilitesNIM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 500K 1M 1.5M

More info and screens

1

3. Growth

3.1 Past

NIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.37%, which is quite impressive.
The earnings per share for NIM have been decreasing by -54.56% on average. This is quite bad
Looking at the last year, NIM shows a small growth in Revenue. The Revenue has grown by 1.29% in the last year.
NIM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.91% yearly.
EPS 1Y (TTM)107.37%
EPS 3Y-54.56%
EPS 5YN/A
EPS Q2Q%47.38%
Revenue 1Y (TTM)1.29%
Revenue growth 3Y-2.91%
Revenue growth 5YN/A
Sales Q2Q%11.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NIM Yearly Revenue VS EstimatesNIM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 1M 2M 3M 4M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 35.96, the valuation of NIM can be described as expensive.
The average S&P500 Price/Earnings ratio is at 28.87. NIM is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 35.96
Fwd PE N/A
NIM Price Earnings VS Forward Price EarningsNIM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NIM Per share dataNIM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

NIM has a Yearly Dividend Yield of 3.62%.
NIM's Dividend Yield is a higher than the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 3.62%

5.2 History

NIM has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of NIM decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
NIM Yearly Dividends per shareNIM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NIM Yearly Income VS Free CF VS DividendNIM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 0 2M -2M 4M 6M 8M

More info and screens

NUVEEN SELECT MATURIT MUNI

NYSE:NIM (4/28/2025, 8:27:45 PM)

9.35

+0.03 (+0.32%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)12-02 2024-12-02
Earnings (Next)06-02 2025-06-02
Inst Owners37.23%
Inst Owner Change0.89%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap116.41M
Analysts0
Price TargetN/A
Short Float %0.09%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield 3.62%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date04-15 2025-04-15 (0.0275)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 35.96
Fwd PE N/A
P/S 26.22
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)0.26
EY2.78%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.36
BVpS9.57
TBVpS9.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 2.76%
ROCE 3.13%
ROIC 2.48%
ROICexc 2.51%
ROICexgc 2.51%
OM 84.12%
PM (TTM) 73.99%
GM 85.76%
FCFM N/A
ROA(3y)1.44%
ROA(5y)N/A
ROE(3y)1.44%
ROE(5y)N/A
ROIC(3y)2.15%
ROIC(5y)N/A
ROICexc(3y)2.15%
ROICexc(5y)N/A
ROICexgc(3y)2.15%
ROICexgc(5y)N/A
ROCE(3y)2.72%
ROCE(5y)N/A
ROICexcg growth 3Y-1.6%
ROICexcg growth 5YN/A
ROICexc growth 3Y-1.6%
ROICexc growth 5YN/A
OM growth 3Y-0.12%
OM growth 5YN/A
PM growth 3Y-53.19%
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 50.2
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.37%
EPS 3Y-54.56%
EPS 5YN/A
EPS Q2Q%47.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.29%
Revenue growth 3Y-2.91%
Revenue growth 5YN/A
Sales Q2Q%11.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.05%
EBIT growth 3Y-3.02%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A